Unfavorable cytokine and adhesion molecule profiles during and after pregnancy, in women with gestational diabetes mellitus

Sattar, 2002, Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?, BMJ, 325, 157, 10.1136/bmj.325.7356.157 Reaven, 2003, The insulin resistance syndrome, Curr Atheroscler Rep, 5, 364, 10.1007/s11883-003-0007-0 Liu, 2012, Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium, Zhonghua Fu Chan Ke Za Zhi, 47, 436 Ziccardi, 2002, Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year, Circulation, 105, 804, 10.1161/hc0702.104279 Kautzky-Willer, 2001, Increased plasma leptin in gestational diabetes, Diabetologia, 44, 164, 10.1007/s001250051595 Atègbo, 2006, Modulation of adipokines and cytokines in gestational diabetes and macrosomia, J Clin Endocrinol Metab, 91, 4137, 10.1210/jc.2006-0980 Ridker, 2000, Novel risk factors and markers for coronary disease, Adv Intern Med, 45, 391 Koch, 1995, Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1, Nature, 376, 517, 10.1038/376517a0 Cominacini, 1997, E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress, Diabetologia, 40, 584, 10.1007/s001250050719 Basi, 2006, Microalbuminuria as a target to improve cardiovascular and renal outcomes, Am J Kidney Dis, 47, 927, 10.1053/j.ajkd.2006.02.182 Strazzullo, 2007, Uric acid and oxidative stress: relative impact on cardiovascular risk?, Nutr Metab Cardiovasc Dis, 17, 409, 10.1016/j.numecd.2007.02.011 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, 1039, 10.2337/diab.28.12.1039 López-Tinoco, 2012, Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus, Cytokine, 58, 14, 10.1016/j.cyto.2011.12.004 Roca-Rodríguez, 2012, Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus, Diabetes Metab Res Rev, 28, 542, 10.1002/dmrr.2313 Di Cianni, 2007, C-reactive protein and metabolic syndrome in women with previous gestational diabetes, Diabetes Metab Res Rev, 23, 135, 10.1002/dmrr.661 Xu, 2014, Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis, PLOS ONE, 9, e87863, 10.1371/journal.pone.0087863 Meyers-Seifer, 1996, Lipid levels in former gestational diabetic mothers, Diabetes Care, 19, 1351, 10.2337/diacare.19.12.1351 Retnakaran, 2010, Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum, Clin Endocrinol (Oxf), 73, 476 Saucedo, 2011, Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes, Arch Med Res, 42, 318, 10.1016/j.arcmed.2011.06.009 McLachlan, 2006, Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy, Diabetes Metab Res Rev, 22, 131, 10.1002/dmrr.591 Friedman, 2008, Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum, Diabetes, 57, 606, 10.2337/db07-1356 Morisset, 2011, Circulating interleukin-6 concentrations during and after gestational diabetes mellitus, Acta Obstet Gynecol Scand, 90, 524, 10.1111/j.1600-0412.2011.01094.x Vitoratos, 2008, Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes, Hormones (Athens), 7, 230, 10.14310/horm.2002.1202 Kirwan, 2002, TNF-alpha is a predictor of insulin resistance in human pregnancy, Diabetes, 51, 2207, 10.2337/diabetes.51.7.2207 Roca-Rodríguez, 2014, Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus, J Endocrinol Invest, 37, 503, 10.1007/s40618-013-0045-6 Göbl, 2013, Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT?, Am J Physiol Endocrinol Metab, 304, E524, 10.1152/ajpendo.00461.2012 Sokup, 2012, Elevation of sE-selectin levels 2–24 months following gestational diabetes is associated with early cardiometabolic risk in nondiabetic women, Int J Endocrinol, 2012, 278050, 10.1155/2012/278050 Lawrence, 2002, Elevation of soluble E-selectin levels following gestational diabetes is restricted to women with persistent abnormalities of glucose regulation, Clin Endocrinol (Oxf), 56, 335, 10.1046/j.1365-2265.2002.01473.x Fasching, 1996, Elevated circulating adhesion molecules in NIDDM – potential mediators in diabetic macroangiopathy, Diabetologia, 39, 1242, 10.1007/BF02658518 Fasching, 1996, Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus, J Clin Endocrinol Metab, 81, 4313